Advanced Aesthetic Technologies, Inc. (AAT) has announced that its partner in China, Lanzhou Biotechnique Development Co., Ltd. (LanDev), has secured regulatory approval to market Algeness® VL, a 2.5% ...
SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...